A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Inhibrx Biosciences, Inc
EpicentRx, Inc.
ImmunityBio, Inc.
Innovent Biologics (Suzhou) Co. Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Boston Scientific Corporation
Daiichi Sankyo
Amgen
Traws Pharma, Inc.
Amgen
Jiangsu Simcere Pharmaceutical Co., Ltd.
HealthCare Global Enterprise Ltd.
Sanofi
BioVex Limited
Sanofi
AstraZeneca